Acadia Pharmaceuticals | ACAD - Eigenkapital Und Reserven

Aktienkurs
21.74
Täglich Wechseln
-0.83 -3.68%
Monatlich
-1.05%
Jährlich
49.11%
Q2 Prognose
21.53




Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
ALKERMES USD 1.82B 85.86M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Cara Therapeutics USD 27.87M 5.06M 2025-09
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Cytokinetics USD -659.62M 138.5M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Incyte USD 5.17B 516.28M 2025-12
J&J USD 78.47B 0 2025-09
Moderna USD 8.65B 680M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Prothena USD 280.47M 14.51M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12